Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro M Rodrigues

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Hepatology (Baltimore, Md.)|August 3, 2023
Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitisKevin De Muynck, Lander Heyerick, Federico F De Ponti, et al.
Clinical Reviews in Allergy & Immunology|January 7, 2021
Are Physicochemical Properties Shaping the Allergenic Potency of Animal Allergens?Joana Costa, Caterina Villa, Kitty Verhoeckx, et al.
Journal of Hepatology|June 24, 2022
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammationIbone Labiano, Aloña Agirre-Lizaso, Paula Olaizola, et al.
Gastroenterology|December 14, 2023
Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in CholangiocarcinomaMonika Lewinska, Ekaterina Zhuravleva, Letizia Satriano, et al.
British Journal of Cancer|July 23, 2020
Current and novel therapeutic opportunities for systemic therapy in biliary cancerJosé J G Marin, Maria Giuseppina Prete, Angela Lamarca, et al.
British Journal of Cancer|July 6, 2021
Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancerJosé J G Marin, Maria Giuseppina Prete, Angela Lamarca, et al.
Gut|September 10, 2020
TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanismsAitor Esparza-Baquer, Ibone Labiano, Omar Sharif, et al.
Journal of Hepatology|February 26, 2022
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental modelsPaula Olaizola, Pui Yuen Lee-Law, Maite G Fernandez-Barrena, et al.
Signal Transduction and Targeted Therapy|April 28, 2026
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growthAloña Agirre-Lizaso, Maider Huici-Izagirre, Colm J O'Rourke, et al.
Hepatology (Baltimore, Md.)|January 14, 2022
Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipidsMikel Ruiz de Gauna, Francesca Biancaniello, Francisco González-Romero, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Hepatology (Baltimore, Md.)|August 3, 2023
Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitisKevin De Muynck, Lander Heyerick, Federico F De Ponti, et al.
Clinical Reviews in Allergy & Immunology|January 7, 2021
Are Physicochemical Properties Shaping the Allergenic Potency of Animal Allergens?Joana Costa, Caterina Villa, Kitty Verhoeckx, et al.
Journal of Hepatology|June 24, 2022
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammationIbone Labiano, Aloña Agirre-Lizaso, Paula Olaizola, et al.
Gastroenterology|December 14, 2023
Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in CholangiocarcinomaMonika Lewinska, Ekaterina Zhuravleva, Letizia Satriano, et al.
British Journal of Cancer|July 23, 2020
Current and novel therapeutic opportunities for systemic therapy in biliary cancerJosé J G Marin, Maria Giuseppina Prete, Angela Lamarca, et al.
British Journal of Cancer|July 6, 2021
Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancerJosé J G Marin, Maria Giuseppina Prete, Angela Lamarca, et al.
Gut|September 10, 2020
TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanismsAitor Esparza-Baquer, Ibone Labiano, Omar Sharif, et al.
Journal of Hepatology|February 26, 2022
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental modelsPaula Olaizola, Pui Yuen Lee-Law, Maite G Fernandez-Barrena, et al.
Signal Transduction and Targeted Therapy|April 28, 2026
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growthAloña Agirre-Lizaso, Maider Huici-Izagirre, Colm J O'Rourke, et al.
Hepatology (Baltimore, Md.)|January 14, 2022
Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipidsMikel Ruiz de Gauna, Francesca Biancaniello, Francisco González-Romero, et al.
Pageof 12